Abstract
Pharmaceutical R&D is organized around prioritized investments, delivering on assets with the greatest return of investments Linear sequencing of trials and financial risks are determinants of speed in an enterprise There is less flexibility in leveraging expertise around priorities that are thrust on the system by external forces This commentary provides an insight into enabling warp speed using a hypervelocity mindset for mobilizing resources and scientific creativity, for accelerated timelines in response to pandemics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
